Laura Carter - 30 Jun 2021 Form 4 Insider Report for Gossamer Bio, Inc. (GOSS)

Role
Chief Scientific Officer
Signature
/s/ Jeff Boerneke, Attorney-in-Fact
Issuer symbol
GOSS
Transactions as of
30 Jun 2021
Net transactions value
$0
Form type
4
Filing time
01 Jul 2021, 16:02:19 UTC
Next filing
26 Oct 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GOSS Common Stock Award $0 +25,000 +34% $0.000000 97,683 30 Jun 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a restricted stock unit award, which will vest on the first anniversary of the grant date in accordance with the terms of the award and subject to the Reporting Person's continuous service to the Issuer on such vesting date.